Meropenem Friedrich Eberth (Meropenem)

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

• Complicated intra‑abdominal infections: provides clinical cure and microbiological eradication.
• Complicated urinary tract infections: eliminates resistant Gram‑negative pathogens.
• Hospital‑acquired pneumonia: achieves rapid bacterial clearance.
• Ventilator‑associated pneumonia: improves survival in critically ill patients.
• Severe sepsis and septic shock: supports hemodynamic stabilization by controlling infection.

• Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and bacterial death. The drug is resistant to most β‑lactamases, allowing activity against a wide range of Gram‑negative and Gram‑positive organisms.

Adverse reactions to meropenem can range from mild to severe and should be monitored during therapy.

Common Side Effects

• Diarrhea: often mild and self‑limiting.
• Nausea: may occur with rapid infusion.
• Headache: transient and usually resolves.
• Rash: mild erythematous skin eruptions.
• Elevated liver enzymes: transient increase in transaminases.
• Injection site pain: discomfort at the IV site.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Seizures: especially in patients with renal impairment or CNS disease.
• Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.
• Thrombocytopenia: marked drop in platelet count.
• Acute interstitial nephritis: renal inflammation.
• Stevens‑Johnson syndrome: rare but life‑threatening skin reaction.

Meropenem should be used with caution in specific clinical situations.

• Renal impairment: adjust dose based on creatinine clearance.
• History of seizures: monitor neurologic status closely.
• Concomitant valproic acid: risk of reduced valproate levels.
• Allergic history: assess for β‑lactam hypersensitivity before initiation.
• Pregnancy and lactation: weigh potential benefits against unknown fetal risk.
• Storage: Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: may decrease valproate concentrations, risking seizure breakthrough.
• Probenecid: can increase meropenem plasma levels, raising toxicity risk.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: additive nephrotoxicity; monitor renal function.
• Loop diuretics: potential for electrolyte disturbances; check labs.
• Anticoagulants (e.g., warfarin): may affect INR; monitor coagulation parameters.